X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/07/12/2477834/13009/en/Catalyst-Pharmaceuticals-Announces-Settlement-of-U-S-Patent-Litigation-and-Resolution-of-Litigation-Challenging-Ruzurgi-Approval-with-Jacobus-Pharmaceutical.html
https://www.globenewswire.com/news-release/2022/02/03/2378495/13009/en/Catalyst-Pharmaceuticals-Reports-that-the-FDA-Marketing-Approval-Previously-Granted-for-Ruzurgi-is-No-Longer-Valid.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209321
https://www.globenewswire.com/news-release/2022/01/28/2375214/13009/en/Catalyst-Pharmaceuticals-Announces-Issuance-of-Mandate-by-the-U-S-Court-of-Appeals-for-the-11th-Circuit-Directing-the-District-Court-Judge-in-Catalyst-s-Lawsuit-Against-the-FDA-to-.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-6-2021-1633509984.pdf
https://www.fiercepharma.com/pharma/ruling-for-catalyst-u-s-appeals-court-calls-fda-approval-ruzurgi-arbirbitrary-capricious-and
https://www.pharmacompass.com/pdf/news/jacobus-pharmaceuticals-issues-voluntary-worldwide-recall-of-ruzurgi-10-mg-1631596573.pdf
https://endpts.com/an-incensed-catalyst-pharma-sues-the-fda-accusing-agency-of-bowing-to-political-pressure-and-breaking-federal-law/
https://www.statnews.com/pharmalot/2019/06/10/jacobus-catalyst-drug-prices-rare-diseases/
https://endpts.com/with-a-substantial-discount-to-catalysts-firdapse-is-jacobus-poised-to-win-physician-payer-support-for-off-label-adult-use/
Market Place
Share 
